125 related articles for article (PubMed ID: 21950989)
1. The role of regularity and synchrony of cerebellar Purkinje cells for pathological nystagmus.
Glasauer S; Rössert C; Strupp M
Ann N Y Acad Sci; 2011 Sep; 1233():162-7. PubMed ID: 21950989
[TBL] [Abstract][Full Text] [Related]
2. Aminopyridines for the treatment of cerebellar and ocular motor disorders.
Strupp M; Kalla R; Glasauer S; Wagner J; Hüfner K; Jahn K; Brandt T
Prog Brain Res; 2008; 171():535-41. PubMed ID: 18718350
[TBL] [Abstract][Full Text] [Related]
3. 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.
Kalla R; Glasauer S; Büttner U; Brandt T; Strupp M
Brain; 2007 Sep; 130(Pt 9):2441-51. PubMed ID: 17664175
[TBL] [Abstract][Full Text] [Related]
4. Modelling drug modulation of nystagmus.
Glasauer S; Rössert C
Prog Brain Res; 2008; 171():527-34. PubMed ID: 18718349
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus.
Kalla R; Spiegel R; Claassen J; Bardins S; Hahn A; Schneider E; Rettinger N; Glasauer S; Brandt T; Strupp M
J Neuroophthalmol; 2011 Dec; 31(4):320-5. PubMed ID: 21734596
[TBL] [Abstract][Full Text] [Related]
6. Potassium channels, the cerebellum, and treatment for downbeat nystagmus.
Leigh RJ
Neurology; 2003 Jul; 61(2):158-9. PubMed ID: 12874391
[No Abstract] [Full Text] [Related]
7. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine.
Strupp M; Kalla R; Dichgans M; Freilinger T; Glasauer S; Brandt T
Neurology; 2004 May; 62(9):1623-5. PubMed ID: 15136697
[TBL] [Abstract][Full Text] [Related]
8. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
Strupp M; Schüler O; Krafczyk S; Jahn K; Schautzer F; Büttner U; Brandt T
Neurology; 2003 Jul; 61(2):165-70. PubMed ID: 12874393
[TBL] [Abstract][Full Text] [Related]
9. Update on the pharmacotherapy of cerebellar and central vestibular disorders.
Kalla R; Teufel J; Feil K; Muth C; Strupp M
J Neurol; 2016 Apr; 263 Suppl 1():S24-9. PubMed ID: 27083881
[TBL] [Abstract][Full Text] [Related]
10. 4-aminopyridine restores visual ocular motor function in upbeat nystagmus.
Glasauer S; Kalla R; Büttner U; Strupp M; Brandt T
J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):451-3. PubMed ID: 15716550
[TBL] [Abstract][Full Text] [Related]
11. The effect of 3,4-diaminopyridine on the patients with hereditary pure cerebellar ataxia.
Tsunemi T; Ishikawa K; Tsukui K; Sumi T; Kitamura K; Mizusawa H
J Neurol Sci; 2010 May; 292(1-2):81-4. PubMed ID: 20181362
[TBL] [Abstract][Full Text] [Related]
12. Potassium channel blocker 4-aminopyridine is effective in interictal cerebellar symptoms in episodic ataxia type 2--a video case report.
Löhle M; Schrempf W; Wolz M; Reichmann H; Storch A
Mov Disord; 2008 Jul; 23(9):1314-6. PubMed ID: 18442126
[TBL] [Abstract][Full Text] [Related]
13. Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus.
Feil K; Bremova T; Muth C; Schniepp R; Teufel J; Strupp M
Cerebellum; 2016 Feb; 15(1):38-42. PubMed ID: 26519380
[TBL] [Abstract][Full Text] [Related]
14. Effect of 3,4-diaminopyridine on the postural control in patients with downbeat nystagmus.
Sprenger A; Zils E; Rambold H; Sander T; Helmchen C
Ann N Y Acad Sci; 2005 Apr; 1039():395-403. PubMed ID: 15826992
[TBL] [Abstract][Full Text] [Related]
15. The origin of downbeat nystagmus: an asymmetry in the distribution of on-directions of vertical gaze-velocity Purkinje cells.
Marti S; Straumann D; Glasauer S
Ann N Y Acad Sci; 2005 Apr; 1039():548-53. PubMed ID: 15827020
[TBL] [Abstract][Full Text] [Related]
16. Effect of 4-aminopyridine on upbeat and downbeat nystagmus elucidates the mechanism of downbeat nystagmus.
Glasauer S; Strupp M; Kalla R; Büttner U; Brandt T
Ann N Y Acad Sci; 2005 Apr; 1039():528-31. PubMed ID: 15827015
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.
Hess E
Neurology; 2011 Nov; 77(22):1996-7; author reply 1997. PubMed ID: 22123782
[No Abstract] [Full Text] [Related]
18. Effect of 4-aminopyridine on gravity dependence and neural integrator function in patients with idiopathic downbeat nystagmus.
Sander T; Sprenger A; Marti S; Naumann T; Straumann D; Helmchen C
J Neurol; 2011 Apr; 258(4):618-22. PubMed ID: 21057959
[TBL] [Abstract][Full Text] [Related]
19. Effects of 4-aminopyridine on nystagmus and vestibulo-ocular reflex in ataxia-telangiectasia.
Shaikh AG; Marti S; Tarnutzer AA; Palla A; Crawford TO; Zee DS; Straumann D
J Neurol; 2013 Nov; 260(11):2728-35. PubMed ID: 23884713
[TBL] [Abstract][Full Text] [Related]
20. In vivo 4-aminopyridine treatment alters the neurotoxin 3-acetylpyridine-induced plastic changes in intrinsic electrophysiological properties of rat cerebellar Purkinje neurones.
Goudarzi I; Kaffashian M; Shabani M; Haghdoost-Yazdi H; Behzadi G; Janahmadi M
Eur J Pharmacol; 2010 Sep; 642(1-3):56-65. PubMed ID: 20638947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
